Breaking News, Collaborations & Alliances

Presage, AstraZeneca Partner on Immuno-Oncology Drugs

Presage's platform will be used in translational analysis to evaluate investigational bispecific antibody combinations.

Presage Biosciences, a translational oncology company that uses CIVO and spatial molecular profiling to understand drug response in the tumor microenvironment (TME), entered an agreement with AstraZeneca to evaluate several investigational bispecific antibody combinations in samples taken from head and neck cancer patients. The work will contribute to advancing AstraZeneca’s portfolio of immuno-oncology agents looking to harness the immune system against cancer. Earlier this month, Pres...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters